EPLAW PATENT BLOG

UK – Napp v Dr Reddy’s and Sandoz

Posted: March 22nd, 2016

Napp Pharmaceutical Holdings Ltd. v (1) Dr Reddy’s Laboratories (UK) Ltd. (2) Sandoz Ltd., High Court of England and Wales (Arnold J), London, UK, 7 March 2016, Neutral Citation Number:  [2016] EWHC 493 (Pat) On 7 March 2016, Arnold J considered whether it was appropriate to hear applications for the trial of a preliminary issue […]

READ MORE

UK – Eli Lilly v. Janssen Sciences Ireland

Posted: March 18th, 2016

Eli Lilly and Company v Janssen Sciences Ireland UC (formally Janssen Alzheimer Immunotherapy), High Court of Justice of England and Wales, Patents Court (Rose J), London UK, 18 February 2016, Neutral Citation Number: [2016] EWHC 313 (Pat) On 18 February 2016, Rose J. refused Janssen’s application for a stay of the invalidity and declaration of […]

READ MORE

UK – Fujifilm Kyowa Biologics v. AbbVie

Posted: March 17th, 2016

Fujifilm Kyowa Biologics Co., Ltd. v AbbVie Biotechnology Ltd., High Court of England and Wales (Carr J), London, UK, 1 March 2016, Neutral Citation Number: [2016] EWHC 425 (Pat) The English High Court has confirmed that it has jurisdiction to grant a declaration that a dosage regime for a biosimilar product would have been anticipated […]

READ MORE

UK – Celltrion v. Biogen Idec

Posted: February 25th, 2016

Celltrion Inc v (1) Biogen Idec Inc. (2) F. Hoffmann-La-Roche AG & (3) Genentech Inc., High Court of Justice of England and Wales, Patents Court (Carr J.), London UK, 22 January 2016, Neutral Citation Number: [2016] EWHC 188 (Pat)  On 22 January 2016, Carr J granted the Claimant’s application for an order that its claim […]

READ MORE

UK – Regeneron v. Kymab and Novo Nordisk

Posted: February 16th, 2016

Regeneron Pharmaceuticals Inc v Kymab Limited and Novo Nordisk A/S, High Court of England and Wales (Carr J), London, UK, 1 February 2016, Neutral Citation Number: [2016] EWHC 87 (Pat).  On 3 February 2016 the Patents Court (Carr J) held that the disputed claims of two of Regeneron’s patents relating to transgenic mice used for […]

READ MORE

ES – Astrazeneca v. Laboratorios Alter

Posted: February 15th, 2016

On 21st December 2015, The Supreme Court handed down a decision in the case of AstraZeneca AB & others v Laboratorios Alter and & others (EDJ 2015/244058). AstraZeneca had filed an action against several generic companies for infringement of an SPC for the product quetaipina: The SPC’s basic patent was EP 228. EP 228 was […]

READ MORE

UK – Electromagnetic Geoservices v Petroleum Geo-Services & ors

Posted: January 18th, 2016

Electromagnetic Geoservices ASA v Petroleum Geo-Services ASA and Others, High Court of England and Wales (Birss J), London, UK, 13 January 2016, Neutral Citation Number: [2016] EWHC 27 (Pat) This was an interlocutory case management hearing before Mr Justice Birss in a case concerning allegations of infringement of EP (UK) 1 256 019, a patent […]

READ MORE

NL – Agfa v. Fujifilm

Posted: December 22nd, 2015

Agfa Graphics N.V. v. Fujifilm Manufacturing Europe B.V.; Fujifilm Europe B.V. and Fujifilm Corporation, District Court of The Hague, the Netherlands, 27 November 2015, Case number 494257 / KG ZA 15-1216. The present preliminary injunction proceedings initiated by Agfa against Fujifilm relate to certain lithographic plates manufactured and sold by Fujifilm that, according to Agfa, […]

READ MORE

UK – Mylan v. Warner-Lambert / Abuse

Posted: December 9th, 2015

Generics (UK) Limited trading as Mylan v Warner-Lambert Company LLC, High Court of England and Wales (Arnold J), London, UK, 25 November 2015, Neutral Citation Number: [2015] EWHC 3370 (Pat) Arnold J has struck out Warner-Lambert’s conditional application to amend a patent held invalid at first instance, and which was subject to ongoing appeal proceedings. […]

READ MORE